Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #8279
Reference
MSAN(2024)56
Name
Lanreotide 60mg/0.5ml, 90mg/0.5ml and 120mg/0.5ml solution for injection pre-filled syringes
Categories
Scottish Government
Organization
Scottish Government Health and Social Care Department
Keywords
NHS
Scotland
Health Boards
Pharmaceutical Services
Supplies
Drug Shortages
Description
Advanz Pharma’s lanreotide 60mg/0.5ml, 90mg/0.5ml and 120mg/0.5ml solution for injection pre-filled syringes are unavailable until at least end of November 2024.
New patient referrals to homecare providers for Advanz Pharma’s lanreotide 60mg/0.5ml, 90mg/0.5ml and 120mg/0.5ml solution for injection pre-filled syringes will not be accepted.
Ipsen's lanreotide (Somatuline Autogel®) 60mg/0.5ml, 90mg/0.5ml and 120mg/0.5ml solution for injection pre-filled syringes remain available and can support increased demand.
Contact Name
Contact Email
Contact Address
Created
2024-09-24 12:25:00
Click to go back to homepage